Current Treatment of Sacral Giant Cell Tumour of Bone: a Review

Author： Shen CC Li H Shi ZL Tao HM Yang ZM

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.40, Iss.2, 2012-03, pp. : 415-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Use of mTOR Inhibitors for the Treatment of Subependymal Giant Cell Astrocytomas and Epilepsy in Patients with TSC

Current Medicinal Chemistry, Vol. 23, Iss. 37, 2016-12 ,pp. : 4260-4269

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis and Treatment of Giant Cell Arteritis

By Cantini Fabrizio

Drugs & Aging, Vol. 25, Iss. 4, 2008-01 ,pp. : 281-297

Adis International

Access to resources Recommend Favorite

Tumour Necrosis Factor Modulation for Treatment of Alzheimer's Disease: Rationale and Current Evidence

By Tobinick Edward

CNS Drugs, Vol. 23, Iss. 9, 2009-09 ,pp. : 713-725

Adis International

Access to resources Recommend Favorite

Treatment of visceral leishmaniasis: a review of current treatment practices

By Rosenthal Eric Marty Pierre

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 8, 2002-08 ,pp. : 1101-1108

Informa Healthcare

Access to resources Recommend Favorite

Pamidronate: A Review of its Use in the Management of Osteolytic Bone Metastases, Tumour-Induced Hypercalcaemia and Paget's Disease of Bone

By Coukell A.J. Markham A.

Drugs & Aging, Vol. 12, Iss. 2, 1998-02 ,pp. : 149-168

Adis International

Access to resources Recommend Favorite